Morshed Kamal, Gołabek Wiesław, Szymański Marcin, Olszański Witold
Klinika Otolaryngologii i Onkologii Laryngologicznej AM w Lublinie.
Otolaryngol Pol. 2005;59(2):225-8.
The first voice prosthesis was described in 1972 by Mozolewski. Eight years later Blom and Singer constructed the first commercial prosthesis. In 1988 another prosthesis was presented as Provox system prosthesis. The aim of the study was to describe the technique of tracheoesophageal puncture (TEP) and to present two years results of the technique performed in 21 patients. Primary TEP with immediate implantation of the Provox 2 prosthesis was applied in 16 (76%) patients. In five patients (24%) secondary TEP was performed. All the patient with primary TEP had cricopharyngeal myotomy. In 7 patients the vocal prosthesis was exchanged. In five because of leakage through the valve and in two patients the vocal prosthesis was extruded. Leakage around the prosthesis occurred in two patients with secondary TEP. The mean device-related lifetime was 216 days and ranged from 30 to 540 days. In non-radiated patients the lifetime of the prosthesis was 255 days and in patients after radiotherapy the lifetime was 150 days. In all the patients the prosthetic voice was more similar to normal voice than in patients with esophageal speech. The implantation of the voice prosthesis is a simple method of restoring of a good quality voice enabling communication.
1972年，莫佐列夫斯基首次描述了人工喉。八年后，布洛姆和辛格制造出了首个商用人工喉。1988年，另一种人工喉作为普洛沃克斯系统人工喉问世。本研究的目的是描述气管食管穿刺（TEP）技术，并展示在21例患者中实施该技术的两年结果。16例（76%）患者采用了首次TEP并立即植入普洛沃克斯2型人工喉。5例（24%）患者进行了二次TEP。所有首次TEP的患者均进行了环咽肌切开术。7例患者更换了人工喉。5例是因为瓣膜渗漏，2例是人工喉脱出。2例二次TEP患者的人工喉周围出现渗漏。与装置相关的平均使用期限为216天，范围在30至540天之间。未接受放疗的患者人工喉使用期限为255天，放疗后的患者为150天。在所有患者中，与食管发音的患者相比，人工喉发出的声音更接近正常声音。植入人工喉是恢复高质量嗓音以实现交流的一种简单方法。
